CCELL

C-Cell is a South Korean biotechnology company specializing in the development of next-generation Natural Killer (NK) cell therapies for cancer treatment. The company utilizes its proprietary C-NK platform to achieve high-purity and high-efficiency expansion of NK cells, aiming to overcome the limitations of current cell therapies in treating solid tumors. Its lead programs focus on indications such as lung and liver cancers, as well as hematologic malignancies. By leveraging advanced cell engineering and expansion technologies, C-Cell seeks to provide "off-the-shelf" therapeutic solutions that are both scalable and highly potent against diverse tumor environments.